• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性在发生 HNF1A-MODY 相关糖尿病前的肝细胞腺瘤的诊断:小心眨眼。

Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.

机构信息

Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Department of Internal Medicine, Isala Diabetes Center, Zwolle, the Netherlands.

出版信息

Liver Int. 2019 Nov;39(11):2042-2045. doi: 10.1111/liv.14235. Epub 2019 Sep 13.

DOI:10.1111/liv.14235
PMID:31483937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6899532/
Abstract

Hepatocyte nuclear factor 1A (HNF1A) maturity-onset diabetes of the young (MODY) is a monogenetic, autosomal dominantly inherited form of diabetes. HNF1A-MODY is associated with HNF1A-inactivated hepatocellular adenoma (H-HCA) formation. Hepatocellular adenoma (HCA) are benign liver tumours and related complications are rare but serious: hepatic haemorrhage and malignant transformation. Guidelines recommend resection of all HCA in men and do not take any co-occurring metabolic disorders into account. We report a family with HCA preceding diabetes mellitus. Male index patient presented with numerous, irresectable HCA. After initial diagnostic and aetiologic uncertainty HNF1A germline mutation c.815G>A (p.Arg272His) was confirmed 8 years later. No HCA-related complications occurred. His diabetic mother was diagnosed with HCA after severe hepatic haemorrhage years before. HNF1A-MODY should be considered in (non-)diabetic (male) patients with H-HCA. We advocate liver biopsy and, if necessary, genetic analysis to precede any intervention for HCA in males and screening for HCA in HNF1A-MODY patients.

摘要

肝细胞核因子 1A(HNF1A)青年发病的成年型糖尿病(MODY)是一种单基因、常染色体显性遗传的糖尿病形式。HNF1A-MODY 与 HNF1A 失活的肝细胞腺瘤(H-HCA)形成有关。肝细胞腺瘤(HCA)是良性肝肿瘤,相关并发症罕见但严重:肝出血和恶性转化。指南建议对所有男性 HCA 进行切除,且不考虑任何同时存在的代谢紊乱。我们报告了一个先出现肝肿瘤后出现糖尿病的家族。男性指数患者表现出许多不可切除的 HCA。在最初的诊断和病因不确定 8 年后,证实存在 HNF1A 种系突变 c.815G>A(p.Arg272His)。未发生与 HCA 相关的并发症。他患有糖尿病的母亲在严重肝出血多年前被诊断出患有 HCA。(非)糖尿病(男性)患者出现 H-HCA 时应考虑 HNF1A-MODY。我们主张在男性进行 HCA 干预之前进行肝活检,如果有必要,还应进行基因分析,并对 HNF1A-MODY 患者进行 HCA 筛查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f48/6899532/e5e16b4ec592/LIV-39-2042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f48/6899532/e5e16b4ec592/LIV-39-2042-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f48/6899532/e5e16b4ec592/LIV-39-2042-g001.jpg

相似文献

1
Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.男性在发生 HNF1A-MODY 相关糖尿病前的肝细胞腺瘤的诊断:小心眨眼。
Liver Int. 2019 Nov;39(11):2042-2045. doi: 10.1111/liv.14235. Epub 2019 Sep 13.
2
Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.双等位基因HNF1A突变所致原发性肝细胞腺瘤及其与青少年发病的成年型糖尿病3型的共现:病例报告及文献复习
Endocrine. 2020 Mar;67(3):544-551. doi: 10.1007/s12020-019-02138-x. Epub 2019 Nov 21.
3
Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.年轻起病的成人型糖尿病 1 型(HNF1A-MODY)患者的肝腺瘤病:法国系列的临床、放射学和病理学特征。
J Diabetes. 2020 Jan;12(1):48-57. doi: 10.1111/1753-0407.12959. Epub 2019 Jul 10.
4
Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.肝细胞腺瘤中 HNF1A 体细胞突变的谱与 MODY3 患者不同,提示存在遗传毒性损伤。
Diabetes. 2010 Jul;59(7):1836-44. doi: 10.2337/db09-1819. Epub 2010 Apr 14.
5
Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.MODY3 家系中伴有新型 HNF1A 种系突变的原发性肝细胞肿瘤。
J Hepatol. 2013 Oct;59(4):904-7. doi: 10.1016/j.jhep.2013.05.024. Epub 2013 May 23.
6
Maturity-onset diabetes of the young and hepatic adenomatosis - characterisation of a new mutation.青年发病的成年型糖尿病与肝腺瘤病——一种新突变的特征描述
Exp Clin Endocrinol Diabetes. 2013 Jun;121(6):368-71. doi: 10.1055/s-0033-1341519. Epub 2013 Apr 24.
7
Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.诊断肝细胞核因子 1A 单基因糖尿病(HNF1A-MODY)会影响降血糖治疗。
Wien Klin Wochenschr. 2021 Mar;133(5-6):241-244. doi: 10.1007/s00508-020-01770-2. Epub 2020 Nov 27.
8
Maturity onset diabetes of the young due to variants in Croatia.因克罗埃西亚的变异导致的青年发病型糖尿病。
Biochem Med (Zagreb). 2018 Jun 15;28(2):020703. doi: 10.11613/BM.2018.020703. Epub 2018 Apr 15.
9
Molecular classification of hepatocellular adenoma in clinical practice.肝细胞腺瘤的临床分子分类。
J Hepatol. 2017 Nov;67(5):1074-1083. doi: 10.1016/j.jhep.2017.07.009. Epub 2017 Jul 19.
10
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.糖原贮积病Ⅰ型患者肝细胞腺瘤的分子特征。
J Hepatol. 2013 Feb;58(2):350-7. doi: 10.1016/j.jhep.2012.09.030. Epub 2012 Oct 6.

引用本文的文献

1
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications.HNF1A 突变肝腺瘤的基因组和转录组特征突出了分子特征和潜在的治疗意义。
Int J Mol Sci. 2024 Sep 29;25(19):10483. doi: 10.3390/ijms251910483.
2
Scoping review of clinical practice guidelines on the management of benign liver tumours.对良性肝脏肿瘤管理的临床实践指南的范围回顾。
BMJ Open Gastroenterol. 2021 Aug;8(1). doi: 10.1136/bmjgast-2020-000592.

本文引用的文献

1
Natural history of liver adenomatosis: A long-term observational study.肝腺瘤病的自然史:一项长期观察性研究。
J Hepatol. 2019 Dec;71(6):1184-1192. doi: 10.1016/j.jhep.2019.08.004. Epub 2019 Aug 13.
2
Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.年轻起病的成人型糖尿病 1 型(HNF1A-MODY)患者的肝腺瘤病:法国系列的临床、放射学和病理学特征。
J Diabetes. 2020 Jan;12(1):48-57. doi: 10.1111/1753-0407.12959. Epub 2019 Jul 10.
3
Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
Somatic HNF1A 突变在肝细胞腺瘤恶性转化中的作用:MSK-IMPACT 和 TCGA 数据的回顾性分析。
Hum Pathol. 2019 Jan;83:1-6. doi: 10.1016/j.humpath.2018.08.004. Epub 2018 Aug 17.
4
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.肝细胞腺瘤的分子分类与危险因素、出血和恶性转化相关。
Gastroenterology. 2017 Mar;152(4):880-894.e6. doi: 10.1053/j.gastro.2016.11.042. Epub 2016 Dec 7.
5
EASL Clinical Practice Guidelines on the management of benign liver tumours.欧洲肝脏研究学会关于良性肝肿瘤管理的临床实践指南。
J Hepatol. 2016 Aug;65(2):386-98. doi: 10.1016/j.jhep.2016.04.001. Epub 2016 Apr 13.
6
Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.MODY3 家系中伴有新型 HNF1A 种系突变的原发性肝细胞肿瘤。
J Hepatol. 2013 Oct;59(4):904-7. doi: 10.1016/j.jhep.2013.05.024. Epub 2013 May 23.
7
Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.糖原贮积病Ⅰ型患者肝细胞腺瘤的分子特征。
J Hepatol. 2013 Feb;58(2):350-7. doi: 10.1016/j.jhep.2012.09.030. Epub 2012 Oct 6.
8
Changing trends in malignant transformation of hepatocellular adenoma.肝细胞腺瘤恶变的变化趋势。
Gut. 2011 Jan;60(1):85-9. doi: 10.1136/gut.2010.222109.
9
Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation.与肝细胞核因子1α失活相关的家族性肝腺瘤病
Gastroenterology. 2003 Nov;125(5):1470-5. doi: 10.1016/j.gastro.2003.07.012.
10
MULTIPLE ADENOMA (HAMARTOMA) OF THE LIVER TREATED BY SUBTOTAL (90 PERCENT) RESECTION: MORPHOLOGICAL AND FUNCTIONAL STUDIES OF REGENERATION.经次全(90%)肝切除治疗的肝脏多发性腺瘤(错构瘤):再生的形态学与功能研究
Ann Surg. 1964 Apr;159(4):513-9. doi: 10.1097/00000658-196415940-00006.